Collectively, our results suggest that HLA-DR+ CTLs may serve as noncanonical antigen-presenting cells, with CD4+ T cell help - either direct or indirect - acting as a crucial amplifier of their cytotoxic function against BC cells. The gene discussed is CD4; the disease is breast cancer.